三诺生物：2024H1血糖业务毛利率持续提升，盈利能力增强

| --- | --- | --- | |---------------------------------------------------------------------------------------------------|-------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...